]>
IRCT20220504054735N1 IRCT 2022-11-15 Tabriz University of Medical Sciences Magnesium supplement therapy in type2 diabetes Serum magnesium levels in type 2 diabetic patients and effect of magnesium supplement therapy in glycemic control and insulin resistance of these patients 2022-07-06 anticipated 60 Complete https://irct.ir/trial/63979 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: All patients (N=60) who meet the conditions for entering the study, after obtaining personal consent and justifying the objectives of the study, will receive one of the two interventions (supplement or placebo) in the clinic based on the randomized list previously provided to the researcher. The randomization of patients will be in the form of blocks of 4 patients prepared by the website 'www.sealedenvelope.com' in which 2 patients are assigned to the intervention group and 2 others to the control group. Finally, 30 patients will enter the intervention group, and 30 will enter the control group. The researcher will not make any changes to the randomized list of people, Blinding description: The participants would be blinded using a placebo. In addition, data would be sent to the analyzer by using numeral codes, so the analyzer would be unaware of groups. (analyzer blinding). 3 Type 2 diabetes. Intervention 1: The intervention group will receive elemental magnesium in the form of 250 mg magnesium oxide tablets daily for three months. Intervention 2: Control group: Taking placebo, in the form of tablet, once a day, for 3 months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information
public Saba Habibzadeh
5th floor, Arghavan building, No.8, 4th west Ave., Besat Alley, Tavanir Blvd.
Tabriz Iran (Islamic Republic of) 5156966537 +98 41 3328 2003 habibzadeh.saba@gmail.com Tabriz University of Medical Sciences scientific Saba Habibzadeh
5th floor, Arghavan building, No.8, 4th west Ave., Besat Alley, Tavanir Blvd.
Tabriz Iran (Islamic Republic of) 5156966537 +98 41 3328 2003 habibzadeh.saba@gmail.com Tabriz University of Medical Sciences Iran (Islamic Republic of) An adult patient with type 2 diabetes who has been diagnosed and treated for at least one year and been treated with oral medications only. The patient's HbA1c level should be between 7 to 10. The patient should be satisfied to participate in the study. 18 years no limit Both Injecting insulin and taking magnesium and calcium supplements, calcium channel blockers, and diuretics. Renal failure, elevated liver enzymes, inflammatory disease, chronic diarrhea, and pregnancy. Participants should not have been admitted to another clinical trial at the same time. E11 Type 2 diabetes mellitus Rehabilitation Placebo The intervention group will receive elemental magnesium in the form of 250 mg magnesium oxide tablets daily for three months Control group: Taking placebo, in the form of tablet, once a day, for 3 months Insulin resistance. Timepoint: Measurement of blood factors will be done twice (one at the beginning, before the start of the intervention, and the other three months later). Method of measurement: Blood tests. Tabriz University of Medical Sciences Approved 2022-05-11 Ethics committee of Tabriz University of Medical Sciences Faculty of Medicine, next to Imam Reza hospital, Golgasht street Tabriz East Azarbaijan Iran (Islamic Republic of)